Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 65162-724

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 65162-724). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Rabeprazole Sodium Delayed Release Tablets 1)

FDA Label Image

1 (Rabeprazole Sodium Delayed Release Tablets 2)

This is a graphic displaying the mean daytime heartburn scores for a placebo group and groups taking RAB at 10mg and 20mg. The study day is shown on the x-axis and the heartburn scores, ranging from 0 to 4, are shown on the y-axis. The heartburn scores indicate the degree to which the participants experienced heartburn during the day, with 0 being none and 4 being very severe.*

FDA Label Image

1 (Rabeprazole Sodium Delayed Release Tablets 3)

This is a chart showing the mean nighttime heartburn scores of different treatments in a study. The treatments are a placebo, RAB 10mg, and RAB 20mg. The study lasted for 28 days and the heartburn scores ranged from 0 (no heartburn) to 4 (very severe heartburn).*

FDA Label Image

1 (Rabeprazole Sodium Delayed Release Tablets 4)

The text describes a figure labeled as "Figure 4" which presents the mean daytime heartburn scores for a study named RAB-USA-3. The scores are presented for different study days, ranging from 0 to 28, and for different treatments, including a placebo. The heartburn scores range from 0 to 4, where 0 indicates no heartburn and 4 indicates very severe heartburn.*

FDA Label Image

1 (Rabeprazole Sodium Delayed Release Tablets 5)

The image shows the mean nighttime heartburn scores for a study, comparing a placebo group (n=58) to a group taking RAB20mg (n=59). The scores are displayed over time (study days) and range from "None" to "Very Severe".*

FDA Label Image

10 (Rabeprazole Sodium Delayed Release Tablets 6)

This is a medication guide for Rabeprazole Sodium Delayed-release Tablets, available in a PDF format that can be downloaded or scanned using a QR code. The guide includes instructions for pharmacists to dispense it to each patient. The rest of the text includes illegible or garbled characters and cannot be evaluated.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.